Visceral leishmaniasis from a non-endemic Himalayan region of Nepal

Parasitol Res. 2018 Jul;117(7):2323-2326. doi: 10.1007/s00436-018-5887-6. Epub 2018 May 2.

Abstract

Visceral leishmaniasis (VL) is endemic to the southern plains of Nepal. Here, we report the first case of VL from a non-endemic Himalayan region of Nepal. The patient presented with a history of high-grade fever, splenomegaly, and anemia but had not traveled to a VL-endemic region. Visceral leishmaniasis was diagnosed following microscopic detection of the Leishmania species amastigote in a bone marrow aspirate, positive result for the rK39 test, and further validation by nested polymerase chain reaction (PCR). The patient was treated with 5 mg/kg liposomal amphotericin B and was clinically improved upon discharge. Our result suggests that VL is expanding towards non-endemic regions of Nepal, and it should therefore be considered that VL surveillance systems be strengthened, particularly for non-program districts and VL be included as a differential diagnosis in febrile illnesses.

Keywords: Himalayan region; Nepal; PCR; Visceral leishmaniasis.

MeSH terms

  • Amphotericin B / therapeutic use
  • Antigens, Protozoan / immunology
  • Child
  • Diagnosis, Differential
  • Fever / diagnosis
  • Fever / parasitology*
  • Humans
  • Leishmania / isolation & purification*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / epidemiology*
  • Male
  • Nepal / epidemiology
  • Polymerase Chain Reaction
  • Protozoan Proteins / immunology
  • Splenomegaly / parasitology
  • Travel

Substances

  • Antigens, Protozoan
  • Protozoan Proteins
  • liposomal amphotericin B
  • Amphotericin B
  • K39 antigen, Leishmania